Ignite Creation Date:
2024-10-25 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06567691
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
Endoscopic Gastroenterostomy Versus Surgical Gastrojejunostomy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Endoscopic Gastroenterostomy Versus Surgical Gastrojejunostomy for Treatment of Malignant Gastric Outlet Obstruction a Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Recent comparative data suggest that EUS gastroenterostomy offers more durable patency than enteral stents for treatment of malignant GOO leading some endoscopists to suggest that EUS gastroenterostomy should be the preferred endoscopic treatment approach
EUS gastroenterostomy and surgical gastrojejunostomy have been compared in retrospective cohort analysis suggesting a high technical success rate a shorter hospital length of stay for the endoscopic approach 4 Comparison of these techniques has not been reported in controlled prospective fashion A prospective trial is necessary in order to define the optimal interventional management option for treatment of malignant GOO in the context of the contemporary and rapidly evolved range of available endoscopic and surgical treatment options
EUS gastroenterostomy and surgical gastrojejunostomy have been compared in retrospective cohort analysis suggesting a high technical success rate a shorter hospital length of stay for the endoscopic approach 4 Comparison of these techniques has not been reported in controlled prospective fashion A prospective trial is necessary in order to define the optimal interventional management option for treatment of malignant GOO in the context of the contemporary and rapidly evolved range of available endoscopic and surgical treatment options
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None